PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2039122
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2039122
Custom Lasik Surgery Market is estimated to be valued at USD 18.2 Bn in 2026 and is expected to reach USD 27.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 18.2 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.90% | 2033 Value Projection: | USD 27.8 Bn |
The LASIK surgery procedure is carried out for treatment of patients suffering from myopia. Increasing demand for minimally invasive therapies, along with rising prevalence of refractive disorders are expected to boost demand for LASIK surgery procedures over the forecast period. Commercialization of approved LASIK surgery systems is expected to fuel custom LASIK surgery market growth during the forecast period.
Changing lifestyle patterns have led to weakening immunity and an increasing susceptibility to various health problems. Eye related diseases have increased in the recent past. For instance, according to the American Academy of Ophthalmology's 2016 statistics, over 150 million people in the U.S. wear corrective eye wear. Increasing demand for effective treatments is expected to drive demand for custom LASIK procedures.
Rising adoption of merger and acquisition strategies by market players is expected to drive the market growth over the forecast period. For instance, in October 2019, SightMD announced the partnership with Westchester Eye Associates. The partnership is expected to help SightMD expand its presence in the Westchester County, U.S. Moreover, the collaboration has helped Westchester Eye Associates expand the company's offerings in the areas of cataract, glaucoma, LASIK, oculoplastic and pediatric care.
Key players in the market are focused on product approvals and launches to enhance their portfolio, which is expected to propel the market growth over the forecast period. For instance, in June 2018, Johnson & Johnson Vision, received the U.S. Food and Drug Administration (FDA) approval for iDESIGN Refractive Studio a system, which allows the surgeon to take precise measurement of the inner part of the eye for delivering customized LASIK procedure to patients